Efficacy of 1-Year Cavacurmin(®) Therapy in Reducing Prostate Growth in Men Suffering from Lower Urinary Tract Symptoms

We aim to assess the effect of Cavacurmin(®) on prostate volume (PV), lower urinary tract symptoms (LUTS) and micturition parameters in men after 1 year of therapy. From September 2020 to October 2021, data from 20 men with LUTS/benign prostatic hyperplasia and PV ≥40 mL who were on therapy with α1-...

Descripción completa

Detalles Bibliográficos
Autores principales: Milanese, Giulio, Agostini, Edoardo, De Angelis, Maria Vittoria, Pretore, Eugenio, Galosi, Andrea Benedetto, Castellani, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966610/
https://www.ncbi.nlm.nih.gov/pubmed/36836224
http://dx.doi.org/10.3390/jcm12041689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966610/
https://www.ncbi.nlm.nih.gov/pubmed/36836224
http://dx.doi.org/10.3390/jcm12041689

Ejemplares similares